Brophy Wealth Management LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Brophy Wealth Management LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,875 shares of the company's stock, valued at approximately $762,000.

Other institutional investors also recently bought and sold shares of the company. FMR LLC grew its stake in HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company's stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in shares of HCA Healthcare in the second quarter worth about $131,527,000. Darsana Capital Partners LP grew its holdings in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock valued at $369,472,000 after buying an additional 400,000 shares in the last quarter. Meritage Group LP purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $150,548,000. Finally, Holocene Advisors LP increased its position in HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company's stock worth $124,691,000 after purchasing an additional 208,015 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.1 %

HCA stock traded up $0.41 during midday trading on Tuesday, reaching $318.91. The stock had a trading volume of 477,123 shares, compared to its average volume of 1,200,664. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $255.73 and a twelve month high of $417.14. The business has a fifty day simple moving average of $362.09 and a two-hundred day simple moving average of $358.91. The firm has a market cap of $80.78 billion, a price-to-earnings ratio of 14.30, a PEG ratio of 1.23 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.83%. HCA Healthcare's payout ratio is currently 11.85%.

Analyst Ratings Changes

Several research firms have recently weighed in on HCA. KeyCorp decreased their target price on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a research report on Monday, October 28th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Raymond James cut HCA Healthcare from an "outperform" rating to a "market perform" rating in a report on Friday, November 22nd. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 target price on the stock. Finally, Wells Fargo & Company cut HCA Healthcare from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. One analyst has rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $380.29.

Insider Activity

In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm's stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company's stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock valued at $5,608,990 over the last three months. Insiders own 1.70% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.